SCHEMBL14070255

SCHEMBL14070255

Cc1ccc(Nc2ncc3c(Nc4cc(NC(=O)c5cccc(C(F)(F)F)c5)ccc4C)nn(C)c3n2)cn1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 7/20 0.73
ABL1 P00519 3/20 0.59
BMX P51813 3/20 0.59
BCR P11274 2/20 0.59
TNK2 Q07912 2/20 0.59
MAP4K2 Q12851 2/20 0.59
RIPK3 Q9Y572 2/20 0.59
RIPK1 Q13546 1/20 0.59
BRAF P15056 5/20 0.56
LCK P06239 4/20 0.56
SRC P12931 2/20 0.56
SYK P43405 2/20 0.56
DDR1 Q08345 2/20 0.56
MAPK14 Q16539 2/20 0.56
DDR2 Q16832 2/20 0.56
KDR P35968 2/20 0.56
ESYT2 A0FGR8 1/20 0.56
PLEKHG3 A1L390 1/20 0.56
NBAS A2RRP1 1/20 0.56
CNOT1 A5YKK6 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14070246 0.93 BTK (0.72) BTKABL1BMXBCRTNK2
SCHEMBL14070193 0.92 BTK (0.75) BTKABL1BMXBCRTNK2
SCHEMBL14069733 0.91 BTK (0.74) BTKABL1BMXBCRTNK2
SCHEMBL14070244 0.90 BTK (0.72) BTKABL1BMXBCRTNK2
SCHEMBL14070254 0.89 BTK (0.73) BTKABL1BMXBCRTNK2
SCHEMBL14070166 0.87 BTK (0.70) BTKABL1BCRTNK2MAP4K2
SCHEMBL14069588 0.87 BTK (0.67) BTKABL1BMXBCRTNK2
SCHEMBL20558521 0.87 BTK (0.67) BTKABL1BCRTNK2MAP4K2
SCHEMBL14070195 0.87 BTK (0.69) BTKABL1BMXBCRTNK2
SCHEMBL14070242 0.86 BTK (0.69) BTKABL1BRAFLCKSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008112695-A2 PYRAZOLO [3,4-D] PYRIMIDINES AND 1, 2, 5, 6-TETRAAZA- AS- INDACENES AS PROTEIN KINASE INHIBITORS FOR CANCER TREATMENT IRM LLC (BM) 2008-09-18 WO disclosed